CPSA Shanghai Archive
Review Program
2018 Program Chair
Cornelis Hop
Senior Director, Drug Metabolism & Pharmacokinetics
Genentech, USA
Plenary Lectures
Philip Timmerman
EBF
Formerly of Janssen Research & Development, USA
Regulated Bioanalysis:
A Perspective on the Future Benefits and Challenges of Globalisationk
Lei Zhang
Silver Springs, MD
Transporters in Drug Development: Current Status and Contemporary Issues
Keynote Lecture
Zaiqi Wang
Head of Roche Innovation Center Shanghai
Roche, Shanghai, China
Future Prospect of Drug Innovation in China: Challenges and Opportunities
Review Program
2017 Program Chair
Nathan Yates
Associate Professor/Scientific Director, Biomedical Mass Spectrometry Center
University of Pittsburgh, USA
Plenary Lectures
Cornelis Hop
Senior Director, Drug Metabolism & Pharmacokinetics
Genentech, USA
Drug Discovery and Development:
Looking for Needles in a Haystack
Dafong Zhong
Professor and Director of Shanghai Center for Drug Metabolism and Pharmacokinetics Research
Shanghai Institute of Materia Medica, China
Nonclinical and Clinical ADME Studies of Several Innovative Drugs in China
Keynote Lecture
Renuka Pillutla
Executive Director/Lead, Bioanalytical Sciences
Bristol-Myers Squibb, USA
Getting More Drugs to Patients Faster -
The Power of Technology Applications
Review Program
2016 Program Chair
Kelly Dong
Director, DMPK
GlaxoSmithKline, China
Plenary Lectures
Valeriu Damian-Iordache
Director, Modeling & Translational Biology
GlaxoSmithKline, USA
Quantitative Systems Pharmacology - A Key Approach to Reduce Attrition in Drug Discovery and Development
Nathan Yates
Associate Professor of Cell Biology, Department of Cell Biology
University of Pittsburgh School of Medicine, USA
Differential Mass Spectroscopy - Biomarker Discovery from Basic Research to the Clinic
Review Program
2015 Program Chair
Philip Timmerman
Director & Research Fellow
Janssen Research & Development, Belgium
Plenary Lectures
Avijit Ghosh
Director, Mechanism Based Drug Disposition Pharmacodynamics and Metabolism
Janssen Research & Development, USA
Trends, Success Stories, and Works in Progress with Physiologically Based Pharmacokinetic Modeling: On the Optimization of Free Exposure at the Site of Action
Binodh DeSilva
Executive Director of Immunochemistry and Biomarker Development
Bristol-Myers Squibb, USA
Advances In Biologic Therapeutics Development Beyond The Era of Monoclonal Antibodies
Review Program
2014 Program Chair
Jeff Zhang
Head of Metabolism and Pharmacokinetics
Novartis China
Plenary Lectures
Stephen Clarke
Head Drug Metabolism & Pharmacokinetics
GlaxoSmithKline
Human First Metabolism
John Yates
Professor Chemical Biology
The Scripps Research Institute
Exploring Diseases using Proteomics
Review Program
2013 Program Chair
Naidong Weng
Scientific Director, Fellow, & Head of Bioanalytical Chemistry
Janssen Pharmaceuticals
Plenary Lectures
John Newton
Vice President and Global Head, Drug Disposition Projects,
Standards and Innovation
Sanofi
The Impact of Metabolism and Pharmacokinetics in Translational Medicine: What Innovation Has Brought Us and What Challenges Still Exist?
Ian A. Blair
A.N. Richards Professor of Pharmacology
University of Pennsylvania School of Medicine
Biomarker Discovery and Validation: Challenges and Promises
Review Program
2012 Program Chair
Jenny Zheng, Janssen
Plenary Lectures
Leslie Benet, University of California at San Francisco
Predicting Drug Disposition and Drug Dosing Parameters for New Molecular Entities
Thomas Baillie, University of Washington
Targeted Covalent Inhibitors versus Chemically-Reactive Drug Metabolites:
Considerations for Rational Drug Design and Toxicological Risk Assessment
Review Program
2011 Program Chair
Jing-Tao Wu, Millennium Pharmaceuticals
Plenary Lectures
Pete Smith, Senior Vice President, Millennium Pharmaceuticals
Challenges and Future Direction of Oncology Drug Development
Xiangmin Zhang, Fudan University
Multi-dimensional Chromatography-Mass Spectrometry for Protein Analysis
Keynote Lectures
Scott Obach, Pfizer
Stable and Reactive Metabolites in Drug Research
Lester C. Taylor, Shane Tichy, and Na Pi; Agilent Technologies
Simultaneous Determination of the PK Profile of Clozapine and its Metabolites in Rat Plasma Using a High-Resolution 6540 QTOF Instrument
Review Program
2010 Program Chair
Yining Zhao, Ph.D., Pfizer
Plenary Lectures
Charles Tong, Global CMC, Pfizer; George Reid, Analytical R&D, Pfizer
Challenges and Opportunities of Pharmaceutical Regulatory Environment for Analytical Sciences -
An Industrial Perspective
Li Hua, The Academy of Military Medical Sciences
DMPK in Drug Discovery and Development
Keynote Lectures
John Fjeldsted, Agilent Technologies
Chip-Based Technology to Enable Biomarker Analysis
| 